StartUp Nijmegen offers a great electric sit-stand workplace with air conditioning for entrepreneurs. We also help you to realise your entrepreneurial ambitions! You will work in an energetic environment with an entrepreneurial spirit. Would you like to experience it for yourself? Sign up for a free trial sitting day!
StartUp Nijmegen is the success formula for starting entrepreneurs. With: boost programme, workplace (24/7), fellow entrepreneurs, Wi-Fi, meeting rooms, air conditioning, help with administration, tax advice, support in structure and rhythm of working days and a large network. It is much more than just a workplace. It is the place for and by entrepreneurs where meeting, growing and connecting is key.
Kadans Science Partner focuses on the development and operation of industrial and office buildings, in combination with laboratories, cleanrooms, research facilities, climate-controlled spaces and pilot plants for R&D departments of knowledge institutions, education institutes and knowledge-intensive businesses in innovative (top) sectors, such as Food, Life Sciences, Health, Living Environment, Biotechnology, Biobased and High-Tech Semicon.
Kadans Science Partner is uniquely familiar with the needs of innovative organisations and knows how to translate these into profitable, high-quality and sustainable facilities, an optimal positioning of spaces, perfect gross-net ratios (functional floor area) and the ideal layout of, e.g., laboratories.
In Europe, also in Nijmegen, Kadans develops, finances and manages real estate for individual tenants and multitenant science buildings. Contact us if you want to know more!
Radboudumc has several offices and laboratory spaces for startups in Life sciences & Health. These facilities are ideal for those startups who wish to be close to Radboudumc. The start up is facilitated in growing from idea and business plan to a real company, and to innovate in collaboration with Radboudumc. Through SMB Life Sciences (a 100% daughter company of Radboudumc) special prices are offered as well as the support from Briskr Health & High Tech Generator.
For more information on the SMB/Radboudumc workspaces, contact Martien Kriens (06 43 08 83 38) or John van Sambeek (06 51 45 08 27).
Nijmegen is a continuously developing Health and High Tech ecosystem, with many possibilities to establish your business. Would you like to join our ecosystem? Check out the location possibilities in Nijmegen and contact us if you want to know more!
On the campus of the Radboud University there are several high quality research facilities, innovation labs and offices for companies which like to cooperate with the university. Their Place-to-Be is Technology & Science Park Nijmegen: 4 buildings – in total more than 25.000 m2 – on the university campus with high level facilities and modern offices for innovative and science based companies, large and small, startups as well as grownups.
Knowledge, business and innovation come together at Noviotech Campus in Nijmegen. The campus offers state-of-the-art research infrastructure and accommodation for entrepreneurs and researchers in the Life Sciences, Health and High Tech sectors. Over 70 companies, that provide work for 3.400+ employees, create a Health and High Tech network, called Noviotech Campus. The Dutch Top-sector Chemistry organization awarded Noviotech Campus with the iLAB status (InnovationLab), as an appreciation for the quality of support and facilities offered.
Nijmegen is a continuously developing Health and High Tech ecosystem, with many possibilities to establish your business. Would you like to join our ecosystem? Check out the location possibilities in Nijmegen and contact us if you want to know more!
From PhD-student to experienced entrepreneurs, the group of participants in the workshop ‘How to attract capital Investment for your innovation in Health/HighTech’ on February 3 was very diverse. Speaker Thijs Cohen Tervaert, investor and director at INKEF Capital informed us he was trained a medical doctor, but never practiced as one. He now helps organisations in healthcare and pharma to co-fund.
He explained the role of venture capital, the criteria used in selecting the right investments and how even early on in your startup you can prepare for these.
In healthcare you need a longer investment horizon to actually start up a company and make it successful. To make the product market-ready you need the help from hospitals, do clinical studies and find partners in innovation.
Nowadays, Digital Health is high on the agenda. Healthcare and technology have a lot of potential as a combined sector with many beautiful and innovative applications that can improve cure and care.
On the basis of several practical cases, it became clear how INKEF can help to finance and develop the company. We learned that venture capital can take place in different stages of a company, or even in certain focus areas.
At the end of the workshop there was an interesting discussion among the participants how to attract venture capital for their organisation or idea.
We look back on yet another successful workshop from INKEF and Briskr.
Commissioned by the province of Overijssel and together with the lectureship ICT innovations in Care of Hogeschool Windesheim, Health Valley conducted a study into the applications of digitisation in care and its acceleration by corona. What have we learned from corona and what can we retain from it after corona? These questions were put to innovation managers in hospitals, care for the elderly, care for the disabled and home care. The lessons learned are compiled on the website: www.innovatiemanagerindezorg.nl.
Not only did healthcare organisations accelerate the introduction of eHealth during the pandemic; the acceptance and adaptation by users also increased because digital solutions proved to be very useful. The project ‘Learning from Corona’ mapped out the lessons learned and how they can be used to make sustainable use of eHealth applications after the pandemic. After all, at some point citizens – patients and clients – will start asking ‘can it be done digitally’?
Lessons learned bundled together Jolanda van Til, lecturer-researcher at Windesheim: “When the province also seemed interested in the question, we turned it into a project and quickly got to work. We interviewed fourteen innovation managers, did a lot of desk research and finally held two group sessions; meetings with the interviewees to explore the themes and findings in greater depth.” Meanwhile, the most important results of the research, clustered around eight themes, are on the website www.innovatiemanagerindezorg.nl.
Corine Böhmers, innovation manager at Health Valley and also involved in the study: “On this website, innovation managers find all kinds of starting points for implementing and speeding up digital solutions. A wealth of information and an incentive to share knowledge.
There is already a lot; make use of it And that is perhaps the most important result of the study: sharing knowledge, Corine says: “You don’t have to invent the wheel yourself. There are already many step-by-step plans and programmes. You can find them on the website. Look carefully at what is already there and use it to your advantage. Corona has given video-calling an enormous boost. We will probably see some reversal of this later, but hybrid working is here to stay. Look at your neighbours and see how they organise things, and take over what you can use.
Jolanda adds: “During the research and in the group discussions, we already saw a kind of fellow sufferer contact develop. That is very important. The role of innovation manager can be very lonely. Know that exactly the same developments are being worked on elsewhere and learn from each other. The website now offers a wonderful platform for that.”
No matter how transformational your science is nor how robust your funding, your innovation may never make a difference in peoples’ lives without the right team to make it happen. Startups may consider different models of gaining access to expertise and skills, while at the same time remaining lean and agile. They might hire contractors, consultants or freelancers for specific tasks, or they might outsource a project or function to an external supplier altogether. In other words, they may consider a contingent workforce that allows performance on demand.
How do you choose the appropriate outsourcing model for each activity, considering your company ambitions, culture and structure? And how does this change over time?
This Johnson & Johnson Innovation webinar aims to guide you through some principal considerations for developing an outsourcing strategy that might fit your company needs. After a general introduction by 2 Bridge, several guest speakers will discuss what they consider to be critical success factors for growing your business, as well as elaborate on how you might tailor your outsourcing model to fit your needs. Further, the speakers will share insights on how to consider the balance between internal employees on your payroll on the one hand and external contractors and suppliers on the other.
With this webinar we aim to give life sciences entrepreneurs valuable insights and considerations into creating a balanced team of employees and contingent workers.
JLABS and Randstad will address questions such as: How do you position yourself as an attractive employer? How can you be competitive when talent is scarce? And how can you retain talent you’ve hired?
To help bring your innovation to patients and hopefully make a difference in their lives, you’ll need to build and retain a stellar team. It can be an essential ingredient in the mix together with your patented disruptive invention and the funding you acquired. While you can hire consultants and outsource many tasks, most life sciences companies are looking to expand beyond their founding team and recruit their own employees at some point in the company’s development.
But how do you position yourself as an attractive employer? How can you be competitive when talent is scarce? And how can you retain talent you’ve hired?
During this webinar we will be joined by a keynote speaker from Johnson & Johnson Innovation – JLABS Resource Hub member Randstad, experts in recruitment and employment. They will share the latest insights from the current labor market. For instance, they’ll touch upon how the pandemic and “the great resignation” have influenced recruitment. They’ll also discuss current expectations of employees in their professional development.
After the keynote presentation we will be joined by different stakeholders, including experienced life sciences entrepreneurs, who will share their insights and experiences. They will discuss considerations in building a team that fits a company’s development strategy and company culture in different phases of growth.
With this webinar we aim to give life sciences entrepreneurs valuable insights into developing their own recruitment strategy.
Patent protection is already crucial in this early phase, so we help the young entrepreneurs with that. I’ve been guiding them with patent applications, Freedom To Operate studies and more in recent years. And so we will continue to do that in the coming years. Many entrepreneurs, both starting out and experienced, only realize too late how important it is to sit down with a patent attorney at an early stage. And there are several good reasons for doing so.
REASON 1: WE CAN IDENTIFY THE PATENT RIGHTS OF THIRD PARTIES AT AN EARLY STAGE Many entrepreneurs are so busy developing their product, starting a business and finding investors that their competitors’ patent rights are a blind spot. You may know who your competitors are, but do you know if they have relevant patent rights? This is a question that investors frequently ask. So you need to investigate that. Whether you do this yourself, or have it done; it must be done. Otherwise you run the risk of developing a product that infringes on someone else’s intellectual property. Which brings me to the next point.
REASON 2: WE CAN STILL EASILY ADJUST THE DESIGN The earlier you know about third-party patent rights, the easier it often is to make minor adjustments to a design. These adjustments may make it possible to design around the existing patents and still be able to enter the market without infringing them. This can of course also be done at a later stage, but is then often much more expensive. The conversion of an entire production line costs more than adapting a concept.
REASON 3: WE CAN DISCUSS R&D RESULTS AT AN EARLY STAGE Innovative entrepreneurs often overlook two things in the development process. First, they often do not realize that they are making simple but valuable inventions. In addition, they sometimes disclose new products before they are patented. In that case, that invention no longer meets the novelty requirement and they can no longer patent it. By discussing the R&D results with a patent attorney at an early stage, you can avoid these pitfalls.
By looking at this together, we will discover the inventions that seem obvious to you, and you will not disclose anything that should not already be disclosed. At the bottom line, this makes your patent portfolio a lot stronger. This increases the value of your company and your position in the market.
REASON 4: WE INCREASE THE CHANCE OF INVESTMENT At Startlife, where finding investors is an important goal, we often hear that entrepreneurs come across better to investors after we have talked about intellectual property. Because of their improved understanding of the opportunities and threats related to their intellectual property, they exude professionalism and a grasp of the situation. Someone is more likely to invest in an organization that knows what it has already done, or wants to do, in the area of patents.
SMALL INVESTMENT The earlier you start talking to a patent attorney, the more grip you have on the initial steps of your venture. Many people only take this step once their techniques have been further developed. This seems logical, but can end up costing much more time and certainly money. Even a brief conversation with a patent attorney can provide you with so much relevant information for your company that it is well worth the small investment.
